Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CLDX compared with VERA: revenue, margins and what each company keeps, and the suppliers and customers both name
CLDX
Celldex Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
VERA
Vera Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CLDX
Celldex Therapeutics, Inc.
vs
VERA
Vera Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CLDX
Celldex Therapeutics, Inc.
Change
30.10
▲
+0.70%
· post 30.22
Mkt cap
$2.4B
Revenue
$22,000
Q2 FY26
Revenue
$7M
FY24
VERA
Vera Therapeutics, Inc.
Change
30.51
▼
−0.06%
· post 30.99
Closed
Oct 30 '26
Mkt cap
$2.2B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
CLDX
Celldex Therapeutics, Inc.
vs
VERA
Vera Therapeutics, Inc.
30.10
▲
+0.70%
post 30.22
Price
30.51
▼
−0.06%
post 30.99
$2.4B
Mkt cap
$2.2B
Q2 FY26
$22,000
Revenue
—
FY24
$7M
Revenue
—
Change
Change
CLDX
30.10
▲
+0.70%
vs
VERA
30.51
▼
−0.06%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CLDX, solid
VERA, dashed
Supply-chain overlap
Revenue flow
CLDX: latest quarter is a loss; flow not drawable. VERA: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CLDX
1
—
Rockefeller University
unlisted
customer
Shared
0
No shared counterparties.
Only VERA
4
NVS
Novartis
supplier
—
Amplyx
unlisted
supplier
—
Ares
unlisted
supplier
—
Stanford
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier